By Jialing Dai •  October 16, 2008  •  PharmAsia News  •  451 words

SHANGHAI – China has ordered a recall of two batches of acanthopanax-based injections, also know as Siberian ginseng, after reports of serious adverse reactions that caused the death of three patients in Yunan Province, China’s Ministry of Health announced Oct. 11.
According to a notice jointly issued by MOH and China’s State FDA Oct. 14,… Read the rest

By Jialing Dai •  May 26, 2008  •  Securities Industry News  •  294 words

Chinese regulators have ordered brokers to encourage investors to trade online and by telephone in order to minimize the impact of the May 12 Sichuan earthquake on normal market operations. “The first priority for brokerages and futures firms is to ensure the safety of investors and employees,” China Securities Regulatory Commission (CSRC) chairman Shang Fulin… Read the rest

By Alex Dai and Jialing Dai •  October 18, 2007  •  Securities Industry News  •  687 words

In a move to increase cooperation with foreign securities markets, the Shenzhen Stock Exchange (SZSE) has signed memorandums of understanding (MOUs) with a pair of prominent exchanges that have a merger pending–Nasdaq Stock Market and OMX.
On Oct. 16, Nasdaq said that it had signed an information-sharing MOU with the Shenzhen exchange. One day later,… Read the rest